[HTML][HTML] Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis

…, EA Otto, KJ Reidy, KK Sambandam… - Kidney international, 2023 - Elsevier
The diagnosis of nephrotic syndrome relies on clinical presentation and descriptive patterns
of injury on kidney biopsies, but not specific to underlying pathobiology. Consequently, …

Complete remission in the nephrotic syndrome study network

…, MH Mokrzycki, KK Sambandam… - Clinical Journal of the …, 2016 - journals.lww.com
Results We enrolled 441 patients: 116 (27%) had MCD, 142 (32%) had FSGS, 66 (15%) had
membranous nephropathy, and 117 (27%) had other glomerulopathy. The baseline UPC …

Kidney stone pathophysiology, evaluation and management: core curriculum 2023

S Shastri, J Patel, KK Sambandam… - American Journal of Kidney …, 2023 - Elsevier
Kidney stone disease, also known as nephrolithiasis or urolithiasis, is a disorder in which
urinary solutes precipitate to form aggregates of crystalline material in the urinary space. The …

[HTML][HTML] Longitudinal changes in health-related quality of life in primary glomerular disease: results from the CureGN study

…, H Reich, K Reidy, H Rondon, KK Sambandam… - Kidney international …, 2020 - Elsevier
Introduction Prior cross-sectional studies suggest that health-related quality of life (HRQOL)
worsens with more severe glomerular disease. This longitudinal analysis was conducted to …

[HTML][HTML] Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients

…, H Nguyen, J Patel, KK Sambandam… - BMC nephrology, 2022 - Springer
Background Hyperphosphatemia occurs frequently in end-stage renal disease patients on
hemodialysis and is associated with increased mortality. Hyperphosphatemia contributes to …

[HTML][HTML] Collapsing focal segmental glomerulosclerosis resulting from a single dose of zoledronate

JA Neyra, OU Vaidya, A Hendricks, KK Sambandam - Nephron Extra, 2014 - karger.com
Bisphosphonates are commonly used for the treatment of osteoporosis, Paget's disease,
multiple myeloma and hypercalcemia. Collapsing focal segmental glomerulosclerosis (FSGS) …

APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis

…, E Brown, M Kretzler, G Appel, KK Sambandam… - Pediatric …, 2021 - Springer
Background The G1 and G2 alleles of apolipoprotein L1 (APOL1) are common in the Black
population and associated with increased risk of focal segmental glomerulosclerosis (FSGS). …

The basic metabolic profile in heart failure—marker and modifier

A Elfar, KK Sambandam - Current heart failure reports, 2017 - Springer
Purpose of Review The physiologic determinants of each of the components of the basic
metabolic profile in patients with heart failure will be explored. Additionally, the review will …

Multidimensional data integration identifies tumor necrosis factor activation in nephrotic syndrome: a model for precision nephrology

…, EA Otto, KJ Reidy, KK Sambandam… - Medrxiv, 2021 - medrxiv.org
Background Classification of nephrotic syndrome relies on clinical presentation and descriptive
patterns of injury on kidney biopsies. This approach does not reflect underlying disease …

Effective use of loop diuretics in heart failure exacerbation: a nephrologist's view

KK Sambandam, BF Palmer - The American journal of the medical …, 2014 - Elsevier
Unfortunately, patients with congestive heart failure suffer frequent admissions for the
management of fluid overload. Loop diuretics are pivotal in the management of this common …